Pfizer Inc on Tuesday raised its forecast for 2021 COVID-19 vaccine sales by more than 70% to $26 billion and said demand from governments around the world fighting to halt the pandemic could contribute to its growth for years to come.
Trending:
Pfizer sees robust COVID-19 vaccine demand for years, $26B in 2021 sales